Join SeqOne at BSGM 2024 in London! 🇬🇧 We’re looking forward to attending BSGM - The British Society for Genetic Medicine (BSGM) annual conference in London, on November 5th! 🧬 📍 Join us at booth 2 for hands-on demonstrations of our state-of-the-art genomic analysis

🧬 We can’t wait for AMP 2024! 🇨🇦 SeqOne is looking forward to attending the Association for Molecular Pathology (#AMP2024) annual meeting in Vancouver from November 20th to November 23rd. Mark your calendars and come meet us! 📍 Come by Booth 526 to learn more about our

🌟 Live from ASHG 2024 ❄️, the SeqOne team can’t wait to meet you at booth 1002! 🇺🇸 Join us to explore how we’re transforming NGS clinical decision support with our innovative solutions: ▶️ SeqOne DiagAI: AI-powered, rapid variant interpretation with prioritized candidate

🇩🇪 Join SeqOne at BVDH in Berlin - Don't miss out! We're excited to participate in the Berufsverband Deutscher Humangenetiker (BVDH) Conference happening on November 15th and 16th in Berlin! 🧬 📍Visit our booth to experience live demonstrations of our state-of-the-art NGS

🎯 Proud to announce that the SeqOne Platform has achieved IVDR certification as a Class C medical device! 🚀 This landmark certification from GMED marks a crucial milestone in our mission to advance precision medicine through trusted genomic analysis. As one of the first

🧬 Bringing Transparency to AI in Genomics: Introducing SeqOne's DiagAI Score Last month, we unveiled DiagAI Score, our cutting-edge AI-powered system for variant ranking. Today, we’re excited to release how the DiagAI Score dashboard delivers unprecedented transparency and

📣 Live from AMP 2024 in Vancouver! 🇨🇦 The SeqOne team is thrilled to meet you at Booth 526 Join us to explore how we're revolutionizing oncology bioinformatics with our cutting-edge solutions: ▶️ SomaCGP: Unlock complex multigenetic alterations—TMB, MSI, fusions, SNPs, and

x.com/i/article/1861…

SeqOne is heading to Porto! Join us at SPGH 2024 🇵🇹 We're thrilled to announce our participation in the 28th Annual Meeting of the Sociedade Portuguesa de Genética Humana (SPGH), taking place December 5-7 in Porto, Portugal. 📍 Stop by booth 16 to discover how our cutting-edge

See you at the DGP’s Molecular Pathology meeting! 🇩🇪 SeqOne is looking forward to attending the 14. Herbsttreffen der AG Molekularpathologie der Deutschen Gesellschaft für Pathologie (DGP) in Cologne on December 9 & 10. Mark your calendars and come meet us! 🧬 📍 Come by Booth

Customer Success Story: CHU de Reims & SeqOne 🌟 We’re pleased to share a testimonial from Professor Anne-Sophie Lèbre, Clinical Molecular Geneticist at CHU de Reims, highlighting the impact of SeqOne’s genomic solutions: "SeqOne’s combination of flexibility, ease of use, and

🔬 Excited to share new data demonstrating SeqOne's comprehensive genomic profiling (CGP) analysis capabilities as part of an integrated solution with Element Biosciences AVITI Platform and Agilent Technologies SureSelect Cancer CGP Assay! Performance highlights: ✅ Full automation with Magnis NGS

🇻🇳 We're thrilled to announce Gene2Genome Technologies as our newest distributor in Vietnam! This partnership strengthens SeqOne's global mission to revolutionize healthcare through accessible genomic medicine. With Gene2Genome Technology's extensive regional network and our

Rendez-vous au Séminaire de Génétique Clinique ! 🇫🇷 🧬 SeqOne sera présent au 34e Séminaire de Génétique Clinique, organisé sous l’égide de l'Association Française de Génétique Clinique (AFGC) à Grenoble, les 16 et 17 janvier. 📍 Venez rencontrer nos experts pour découvrir nos

We are excited to share new research from the Georges-François Leclerc Cancer Center (CGFL), in which our bioinformatics team helped assess the clinical utility of Oxford Nanpore (Oxford Nanopore) adaptive sampling for analyzing cancer predisposition genes. 🧬 This study establishes

We’re excited for the Festival of Genomics and Biodata! 🇬🇧 SeqOne will be attending the Festival of Genomics and Biodata (The Festival of Genomics & Biodata) in London on January 29th and 30th. #FOG2025 📍 Find us at Booth 67A to meet our team of experts, explore cutting-edge genomic analysis

SeqOne's SomaHRD platform demonstrates exceptional performance in collaboration with Agilent Technologies Technologies and Psomagen Inc.. This new Application Note data confirms SomaHRD's outstanding accuracy in HRD assessment. 🎯 Key performance metrics of our HRD solution: ✅ Superior

📣 Live from the Festival of Genomics & Biodata in London! 🇬🇧 The SeqOne team is looking forward to meeting you at booth 67A! Join us to explore how we're revolutionizing bioinformatics with our cutting-edge solutions: ▶️ SeqOne DiagAI: AI-powered variant interpretation for

Cutting-edge Phenotype-Driven Genomics: How SeqOne is Boosting Diagnostic Efficiency 🧬 Curious about what advanced phenotype-based genomics can do for your lab? Check out our new blog post where we dive into SeqOne’s innovative features and free trials for hands-on experience.

SeqOne is heading to Melbourne! 🇦🇺 We’re thrilled to be attending the Pathology Update 2025, hosted by the Royal College of Pathologists of Australasia (The Royal College of Pathologists of Australasia), alongside Integrated Sciences (Integrated Sciences) in Melbourne, from February 21 to 23! Come say hello and